An Investigation into the Rehabilitative Mechanism of Tuina in the Treatment of Sciatic Nerve Injury
Table 1
Quality control and sequencing information of each sample.
Sample
Raw reads
Clean reads
Q20 (%)
Q30 (%)
Total mapped
1
Sham 1
45996402
45488638
98.24
94.53
44143048 (97.04%)
2
Sham 2
49336984
48784674
98.13
94.3
47295661 (96.95%)
3
Sham 3
48433120
47697864
97.67
93.18
46130890 (96.71%)
4
SNI 1
48311290
47689406
97.73
93.32
46140997 (96.75%)
5
SNI 2
45962802
45466708
98.27
94.63
44134471 (97.07%)
6
SNI 3
46637582
46017056
97.33
92.25
44506803 (96.72%)
7
Tuina 1
46364082
45634588
97.62
93.11
44106643 (96.65%)
8
Tuina 2
46912118
46294222
97.89
93.7
44757906 (96.68%)
9
Tuina 3
49393696
48764848
97.95
93.83
47199260 (96.79%)
Sample: 9 cDNA libraries are Sham group (Sham 1, 2, and 3), SNI group (SNI 1, 2, and 3), and Tuina group (Tuina 1, 2, and 3). Raw reads: amount of original sequence data. Clean reads: amount of sequenced data after filtering. Q20, Q30: percentage of bases greater than 20 and 30 in the total base. Total mapped: the number of clean reads that can be located on the genome.
